44 completed, 17 recruiting, 10 unknown, 3 active not recruiting. 22 Not applicable, 17 Phase 2, 12 Phase 1, 11 Phase 3.
Follow Vaginal Cancer: new trials by email Literature Review of Vaginal Cancer trials Research Report on Vaginal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions Routine-care metastasis-directed radiotherapy - Cervical Cancer, Gynecologic Cancer | Recruiting | Affidea Nu-med Center of Oncological DIagnostics and Therapy | 500 | 2026-10-06 | 2026-10-20 | |
| Vagina-View Safety and Imaging Feasibility Vagina-View (VV) device - Vaginal Cancer | Not applicable | Recruiting | University Health Network, Toronto | 10 | 2026-09-15 | 2026-09-17 |
| Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study Assessment of sexual quality of life - Pelvic Cancer, Anal Cancer | Not applicable | Not yet recruiting | Institut du Cancer de Montpellier - Val d'Aurelle | 42 | 2026-04-02 | 2026-04-13 |
| DESTINY-PANTUMOUR04 Trastuzumab deruxtecan - Adenocarcinoma (NOS), Anal Cancer | Recruiting | AstraZeneca | 100 | 2025-09-18 | 2026-09-25 | |
| E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers E7 TCR-T cells, Aldesleukin - HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma | Phase 1 / Phase 2 | Recruiting | Christian Hinrichs | 15 | 2025-08-11 | 2026-10-06 |
| Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin Belzutifan - Ovarian Cancer, Ovarian Carcinoma | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 32 | 2024-12-20 | 2025-11-05 |
| Enhanced Assistance During Radiotherapy for Unmet Essential Needs Standard assistance, Enhanced assistance - Bone Cancer, Brain Cancer | Not applicable | Completed | Washington University School of Medicine | 33 | 2024-10-04 | 2025-08-26 |
| The Gynecological Cancer Associated Thrombosis (GynCAT) Study Anticoagulant - Cancer-associated Thrombosis, Venous Thromboembolism | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1800 | 2024-04-15 | 2024-09-19 | |
| ASk Questions in GYnecologic Oncology (ASQ-GYO) Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List - Ovarian Cancer, Endometrial Cancer | Not applicable | Completed | Ira Winer | 68 | 2024-04-04 | 2026-08-20 |
| Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer Radiochemotherapy plus interventional radiotherapy - Vaginal Cancer | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 278 | 2024-03-15 | 2025-08-15 | |
| 3D Printed Custom Applicators for HDR BT (DISCO) 3D-printed custom applicator - Gynecologic Cancer, Endometrial Cancer | Not applicable | Recruiting | Royal North Shore Hospital | 10 | 2023-11-24 | 2026-02-06 |
| Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies Reiki therapy - Gynecologic Neoplasm, Brachytherapy | Phase 2 | Recruiting | University of Utah | 70 | 2023-11-14 | 2026-10-14 |
| Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) Fit4Treatment - Ovary Cancer, Endometrial Cancer | Not applicable | Active not recruiting | Northwestern University | 192 | 2023-09-15 | 2026-10-19 |
| SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas SCG142 TCR-T cells - Human Papillomavirus Associated Carcinomas, Cervical Cancer | Phase 1 | Recruiting | The Affiliated Hospital of Qingdao University | 18 | 2023-08-02 | 2024-08-09 |
| Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery Intervention group triads - Vulvar Cancer, Ovarian Cancer | Not applicable | Completed | Indiana University | 47 | 2023-06-14 | 2025-01-28 |
| Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women HPV-16/18 vaccine, Placebo - Cervical Cancer, Vulvar Cancer | Active not recruiting | Shanghai Zerun Biotechnology Co.,Ltd | 5372 | 2023-03-27 | 2025-01-15 | |
| E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers E7 TCR-T cells, Aldesleukin - Cervical Cancer, Throat Cancer | Phase 2 | Recruiting | Christian Hinrichs | 20 | 2023-03-07 | 2026-06-12 |
| NYSCF Scientific Discovery Biobank Biological Sample Collection - ALS, Amyotrophic Lateral Sclerosis | Recruiting | New York Stem Cell Foundation Research Institute | 10000 | 2022-11-10 | 2025-03-03 | |
| Gynaecology Exercise and Mindfulness Study Mindfulness and exercise, Mindfulness - Gynecologic Cancer, Uterus Cancer | Not applicable | Unknown | University of Ulster | 40 | 2022-06-14 | 2022-10-03 |
| Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine HPV Infections, Cervical Cancer Stage IIa | Recruiting | Shanghai Bovax Biotechnology Co., Ltd. | 600 | 2022-05-14 | 2024-04-17 |
Showing 20 of 79. Sign in to see all of them.
Vaginal Neoplasms (79) · Uterine Cervical Neoplasms (68) · Vulvar Neoplasms (51) · Endometrial Neoplasms (34) · Ovarian Neoplasms (33) · Uterine Neoplasms (19) · Fallopian Tube Neoplasms (14) · Papillomavirus Infections (14) · Sarcoma (14) · Condylomata Acuminata (13) · Anus Neoplasms (12) · Carcinoma, Ovarian Epithelial (10) · Penile Neoplasms (10) · Prostatic Neoplasms (9) · Urinary Bladder Neoplasms (8)
Female Urogenital Diseases (79) · Female Urogenital Diseases and Pregnancy Complications (79) · Genital Diseases (79) · Genital Diseases, Female (79) · Neoplasms by Site (79) · Urogenital Diseases (79) · Urogenital Neoplasms (79) · Vaginal Diseases (79) · Genital Neoplasms, Female (77) · Neoplasms (75) · Uterine Diseases (74) · Uterine Cervical Diseases (68) · Uterine Neoplasms (55) · Vulvar Diseases (51) · Adnexal Diseases (34)
Brachytherapy (4) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (4) · Radiotherapy (4) · aldesleukin (4) · fludarabine phosphate (3) · Adoptive Transfer (2) · Cyclophosphamide (2) · Magnetic Resonance Spectroscopy (2) · Paclitaxel (2) · Surgical Procedures, Operative (2) · Surveys and Questionnaires (2) · Vaccines, Synthetic (2) · fludarabine (2) · Amplified Fragment Length Polymorphism Analysis (1) · Anticoagulants (1)
Merck Sharp & Dohme LLC (7) · Shanghai Bovax Biotechnology Co., Ltd. (7) · Memorial Sloan Kettering Cancer Center (5) · Royal Marsden NHS Foundation Trust (4) · Dana-Farber Cancer Institute (3) · M.D. Anderson Cancer Center (3) · National Cancer Institute (NCI) (3) · Christian Hinrichs (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2) · Masonic Cancer Center, University of Minnesota (2) · Northwestern University (2) · Affidea Nu-med Center of Oncological DIagnostics and Therapy (1) · Alliance for Clinical Trials in Oncology (1) · AstraZeneca (1) · Boston Medical Center (1)
United States (38) · China (10) · United Kingdom (8) · France (5) · Italy (4) · Austria (2) · Belgium (2) · Canada (2) · Germany (2) · Netherlands (2) · Spain (2) · Australia (1) · Finland (1) · Poland (1) · Portugal (1)
Clare Shaw, Phd (3) · Christian S Hinrichs, MD (2) · Levi S. Downs, MD (2) · Akila Viswanathan, M.D. (1) · Andrea Pusic, M.D. (1) · Carien L Creutzberg, MD, PhD (1) · Catherine West (1) · Charles Kunos, MD, PhD (1) · Charles Levenback, MD (1) · Christian S Hinrichs, M.D. (1) · David Kushner (1) · Dennis Chi, MD (1)
PMID 27422279, PMID 29269325, PMID 29767739, PMID 33326342, PMID 11230468, PMID 17466514, PMID 18190952, PMID 18768432, PMID 23849695, PMID 24201015, PMID 25278227, PMID 25693011, PMID 25749310, PMID 25823737, PMID 25912208, PMID 26086587, PMID 26101366, PMID 26366475, PMID 26644527, PMID 28789851, PMID 28886907, PMID 29149611, PMID 29211620, PMID 30714987, PMID 30798790, PMID 30982556, PMID 32125711, PMID 32659510, PMID 33676783, PMID 33882792, PMID 34863145, PMID 37667847, PMID 37883461, PMID 38961193, PMID 41166720, PMID 41276263
P30CA043703 (2), 2009 (1), P30CA014520 (1), P30CA060553 (1), R21CA167800 (1), U01CA287904 (1)